Endovascular Aneurysm Repair

Type: Keyphrase
Name: Endovascular Aneurysm Repair
First reported 9 hours ago - Updated 9 hours ago - 1 reports

Endologix's (ELGX) CEO John McDermott on Q3 2014 Results - Earnings Call Transcript

OperatorGreetings, ladies and gentlemen, and welcome to the Endologix Third Quarter 2014 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) ... [Published Seeking Alpha - 9 hours ago]
First reported 17 hours ago - Updated 13 hours ago - 1 reports

Lombard affirms guidance after Q3 results

s EditorLombard Medical (EVAR +8.5%) Q3 results: Revenues: $4.3M (+168.8%); Gross Profit: $1.8M (+200.0%); Operating Expense: ($10.5M) (-69.4%); Operating Loss: ($8.7M) (-55.4%); Net Loss: ($8.5M) (-51.8%); Loss Per Share: ($0.52) (-4.0%); Quick Assets: ... [Published Seeking Alpha - 17 hours ago]
First reported Oct 30 2014 - Updated Oct 30 2014 - 1 reports

One geek's wish: The best convention EVAR

It would figure for me to finally find a genie, finally get the wish and the stupid genie picks the wish:"You get your perfect day."Welp, I better make the most of this. That's easy-peasy for any geek. Heaven is a convention. In my shiny happy headspace, ... [Published Chicago Now - Oct 30 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 1 reports

Lombard Medical Reports Third Quarter 2014 Financial Results

Global Aorfix™ Revenue Up 192 Percent 1 Year-over-Year;U.S. Revenue Grows 75 Percent Sequentially from Q2; Solid Early Adoption in JapanIRVINE, Calif. and LONDON, Oct. 29, 2014 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. ( Nasdaq:EVAR ), a medical device ... [Published WGNT - Oct 29 2014]
First reported Oct 29 2014 - Updated Oct 29 2014 - 1 reports

Abdominal Aortic Aneurysm Repair May Be Riskier for Some

Reuters Health InformationBy David DouglasOctober 29, 2014NEW YORK (Reuters Health) - Comparisons of open and endovascular repair of abdominal aortic aneurysms (AAA) might not be yielding data that's applicable to the real world, researchers say."The ... [Published General Medicine eJournal - Oct 29 2014]
First reported Oct 27 2014 - Updated Oct 27 2014 - 2 reports

TriVascular Announces First Patient Enrollment in the LIFE (Least Invasive Fast-Track EVAR) Study

SANTA ROSA, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- . (Nasdaq:TRIV) announced today the first patient enrollment in the LIFE Study, a multi-center post-market registry. The first LIFE Study patient was treated by Wayne K. Nelson, MD at Bend Memorial ... [Published Pettinga Financial Advisors - Oct 27 2014]
First reported Oct 27 2014 - Updated Oct 27 2014 - 2 reports

Lombard Medical to Present at Upcoming Investor Conferences

IRVINE, Calif. and LONDON, Oct. 27, 2014 (GLOBE NEWSWIRE) -- (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAA), today announced that CEO Simon Hubbert is scheduled to present at the ... [Published Pettinga Financial Advisors - Oct 27 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

EVAR trial results don't sync with real-world outcomes

Endovascular aneurysm repair (EVAR) has a lower 30-day mortality rate than open abdominal aortic aneurysm (AAA) surgery in trials, but rates may not be as low in a real-world setting. Researchers who compared findings from a national clinical database ... [Published Cardiovascular Business - Oct 23 2014]
First reported Oct 20 2014 - Updated Oct 21 2014 - 2 reports

TriVascular Receives FDA Approval for its CustomSeal Technology for Ovation Prime® System

SpecialChem- Oct 21, 2014SANTA ROSA, Calif. -- TriVascular Technologies, Inc. (Nasdaq:TRIV) announced that the U.S. Food and Drug Administration (FDA) has approved CustomSeal Technology for the Ovation Prime System. Withthe Ovation Prime endograft system, ... [Published SpecialChem - Oct 21 2014]
First reported Oct 16 2014 - Updated Oct 17 2014 - 3 reports

Lombard Medical Announces 2014 Third Quarter and Nine-Month Financial Results Release and Conference Call Date

IRVINE, Calif. and LONDON, Oct. 17, 2014 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs3), today announced that it will release its 2014 ... [Published Stock Nod - Oct 17 2014]
First reported Oct 16 2014 - Updated Oct 16 2014 - 2 reports

Sector Update: Health Care Stocks Mixed; HCA Holdings Near Session High After Raising FY14 Earnings Forecast

PFE -1.19%ABT +0.17%MRK -1.53%AMGN -1.16%Health care stocks were mixed, with the NYSE Health Care Sector Index retreating nearly 0.6% while shares of health care companies in the S&P 500 were climbing about 0.1% as a group.In company news, HCA Holdings ... [Published Nasdaq - Oct 16 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 3 reports

Lombard Medical Technologies's Aorfix Endovascular Stent Graft Adopted By

IRVINE, Calif. and LONDON, Oct. 9, 2014 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that its lead product, Aorfix, ... [Published BioPortfolio - Oct 09 2014]

Quotes

...6 million, from an initial stocking order," said CEO Simon Hubbert. "There was no revenue in 2013. The balance of the initial stocking order and additional re-stocking orders, which have already been received, are expected to be shipped in the fourth quarter."
"The differences between randomized clinical trials and real-world practice . . . make it necessary to utilize individual/patient specific risk profiles during conversations between patients and their surgeons prior to surgery" Dr. Isibor J Arhuidese told Reuters Health by email
"We are excited to enroll the first patient in the LIFE Study," stated Dr. Nelson. "The Ovation Prime system is uniquely suited to a Fast-Track protocol due to its low profile and ease of use. Our patient recovered smoothly and went home the next day. The ability to risk stratify AAA patients and offer them a Fast-Track option is compelling for patients, physicians and the hospital. We are looking forward to continued enrollment in the LIFE Study."
"I was impressed with the performance of the CustomSeal Technology," commented Dr. Harlin. "The decrease in the polymer"

More Content

All (70) | News (46) | Reports (0) | Blogs (17) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
Endologix's (ELGX) CEO John McDermott on Q3 201... [Published Seeking Alpha - 9 hours ago]
Lombard affirms guidance after Q3 results [Published Seeking Alpha - 17 hours ago]
One geek's wish: The best convention EVAR [Published Chicago Now - Oct 30 2014]
Lombard Medical Reports Third Quarter 2014 Fina... [Published WGNT - Oct 29 2014]
Abdominal Aortic Aneurysm Repair May Be Riskier... [Published General Medicine eJournal - Oct 29 2014]
TriVascular Announces First Patient Enrollment ... [Published GlobeNewswire: Acquisitions News - Oct 27 2014]
Lombard Medical to Present at Upcoming Investor... [Published GlobeNewswire: Acquisitions News - Oct 27 2014]
TriVascular Announces First Patient Enrollment ... [Published Pettinga Financial Advisors - Oct 27 2014]
Lombard Medical to Present at Upcoming Investor... [Published Pettinga Financial Advisors - Oct 27 2014]
TriVascular Announces First Patient Enrollment ... [Published Benzinga.com - Oct 27 2014]
Lombard Medical to Present at Upcoming Investor... [Published Benzinga.com - Oct 27 2014]
Cordis launches stent graft system [Published Performance Materials Net - Oct 23 2014]
Lombard Medical’s Aorfix Receives Regulatory Ap... [Published Diagnostic & Invasive Cardiology - Oct 23 2014]
EVAR trial results don't sync with real-world o... [Published Cardiovascular Business - Oct 23 2014]
Toshiba Medical opens training centre in Canada [Published Canadian Healthcare Technology - Oct 22 2014]
Market Research Reports, Inc. (www.marketresear... [Published BusinessWeek - Oct 21 2014]
TriVascular Receives FDA Approval for its Custo... [Published SpecialChem - Oct 21 2014]
TriVascular Technologies, Inc. to Hold 2014 Thi... [Published Market Pulse Navigator - Oct 20 2014]
FDA approves TriVascular's CustomSeal for aorti... [Published MassDevice - Oct 20 2014]
End exclamation points NOW!!!!!!!!!!!!!! [Published Chicago Now - Oct 18 2014]
FDA approves TriVascular sealant technology for... [Published North Bay Business Journal - Oct 17 2014]
Lombard Medical Announces 2014 Third Quarter an... [Published GlobeNewswire: Acquisitions News - Oct 17 2014]
Lombard Medical Announces 2014 Third Quarter an... [Published Stock Nod - Oct 17 2014]
Sector Update: Health Care Stocks Still Slumpin... [Published Nasdaq - Oct 16 2014]
Sector Update: Health Care Stocks Mixed; HCA Ho... [Published Nasdaq - Oct 16 2014]
Sector Update: Health Care [Published Nasdaq - Oct 16 2014]
Lombard Medical Technologies Announces First Ao... [Published BioPortfolio - Oct 16 2014]
TriVascular obtains FDA approval for CustomSeal... [Published Medical Devices Business Review - Oct 16 2014]
Lombard Medical Announces First Aorfix(TM) Case... [Published GlobeNewswire: Acquisitions News - Oct 16 2014]
Lombard Medical Announces First Aorfix(TM) Case... [Published A.M. Best - Oct 16 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Wonkette Week In Review: All The Stuff You Miss... [Published Wonkette - Sep 20 2014]
So before we started this week’s list of the ten most-shared-on-Facebook posts of the last week, we had prepared a beautiful 1500-word Dear Shitferbrains piece for you. It was almost certainly the bestest, funniest Dear Shitferbrains EVAR. Or at ...
Cordis Corporation Launches INCRAFT® AAA Stent ... [Published Business Wire Photo/Multimedia News - Sep 10 2014]
FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today the launch of its INCRAFT® AAA Stent Graft System (INCRAFT® System), an ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suffering from infrarenal ...
Cordis Corporation Launches INCRAFT® AAA Stent ... [Published Business Wire News with Multimedia - Sep 10 2014]
FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today the launch of its INCRAFT® AAA Stent Graft System (INCRAFT® System), an ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suffering from infrarenal ...
Cordis Corporation Launches INCRAFT® AAA Stent ... [Published Business Wire Health News - Sep 10 2014]
FREMONT, Calif.--(BUSINESS WIRE)--Cordis Corporation announced today the launch of its INCRAFT® AAA Stent Graft System (INCRAFT® System), an ultra-low profile device for use during endovascular aneurysm repair (EVAR) for patients suffering from infrarenal ...
Sexual violence as a war strategy in Iraq [Published Informed Comment - Aug 15 2014]
By Nazand Begikhani via Your Middle East “These are strategic theories of rape in wartime which have been deliberately practiced by IS jihadists in Syria and now in Iraq,” writes Dr Nazand Begikhani. In the last few days, while the world has been overwhelmed ...
1 2 3 4

Press Releases

sort by: Date | Relevance
TriVascular Announces First Patient Enrollment ... [Published GlobeNewswire: Acquisitions News - Oct 27 2014]
Lombard Medical to Present at Upcoming Investor... [Published GlobeNewswire: Acquisitions News - Oct 27 2014]
Lombard Medical Announces 2014 Third Quarter an... [Published GlobeNewswire: Acquisitions News - Oct 17 2014]
Lombard Medical Announces First Aorfix(TM) Case... [Published GlobeNewswire: Acquisitions News - Oct 16 2014]
Lombard Medical's Aorfix(TM) Endovascular Stent... [Published GlobeNewswire: Acquisitions News - Oct 09 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.